Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Microbial world's use of metals mostly unmapped

July 18, 2010 12:34 pm | by Lawrence Berkeley National Laboratory | News | Comments

Microbes boast a broader and more diverse array of metal-driven chemical processes than scientists imagined. In fact, most have yet to be discovered, according to a first-of-its-kind technique that catalogs all of the metals in a microbe. The method could lead to innovative clean energy...

TOPICS:

Long-term care of HIV survivors needs additional research, attention

July 18, 2010 2:32 am | by Baylor College of Medicine | News | Comments

As more effective treatments extend the lives of people with HIV, physicians need to research how best to provide care for these 'HIV survivors' as they age and acquire other chronic ailments, said experts at Baylor College of Medicine in a commentary that appears today in The Journal of...

TOPICS:

HIV testing should be routine in cancer care

July 18, 2010 12:33 am | by Baylor College of Medicine | News | Comments

In 2006, the U.S. Centers for Disease Control and Prevention recommended routine HIV testing in all healthcare settings as long as patients are given the opportunity to 'opt-out' or refuse the test. That recommendation is not widely followed, but it should be – especially in...

TOPICS:
Advertisement

Groundbreaking New Lung Imaging System

July 17, 2010 10:31 am | by ISRAEL21cdotcom | Videos | Comments

The FDA recently approved a groundbreaking new non-invasive, radiation-free lung imaging system created by Deep Breeze, Ltd, an Israeli company in Or Akiva. It is viewed by some as the most important medical imaging technology since ultrasound. It is being marketed by GE Healthcare in...

TOPICS:

ArmaGen® Re-engineers Erythropoietin for Brain Penetration

July 16, 2010 5:35 pm | by Bio-Medicine.Org | News | Comments

LOS ANGELES , July 16 /- Human erythropoietin (EPO) is a potent neuroprotective agent for multiple brain disorders, including stroke, brain and spinal cord injury, and Parkinson's disease. However, EPO drug development for the brain is limited, because EPO does not cross the blood-brain...

TOPICS:

FDA Consumer Health Information - Stolen Inhalers Pose Risk

July 16, 2010 5:34 pm | by Bio-Medicine.Org | News | Comments

SILVER SPRING, Md. , July 16 /PRNewswire-USNewswire/ -- The public should be on the lookout for stolen inhalers after some were found in a number of pharmacies. The Food and Drug Administration (FDA) says the safety and effectiveness of the stolen Advair Diskus inhalers cannot be assured,...

TOPICS:

China Sky One Medical's Chief Financial Officer's Health Issues to Restrict His Availability to Investors

July 16, 2010 5:34 pm | by Bio-Medicine.Org | News | Comments

HARBIN, China , July 16 /PRNewswire-Asia-FirstCall/ -- China Sky One Medical, Inc. ("China Sky One Medical" or "the Company") (Nasdaq: CSKI ), a leading fully integrated pharmaceutical company producing over-the-counter drugs in the People's Republic of China ("PRC"), today announced that...

TOPICS:

Jiangchuan Macrolide Facility Update

July 16, 2010 12:34 pm | by Bio-Medicine.Org | News | Comments

CHENGDU, China , July 16 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical (NYSE Amex: TPI ), a pharmaceutical company that specializes in patented biopharmaceutical, modernized traditional Chinese medicine and branded generics provides progress update on its Jiangchuan macrolide...

TOPICS:
Advertisement

MR-Guided Focused Ultrasound Symposium Announces Sponsors

July 16, 2010 12:34 pm | by Bio-Medicine.Org | News | Comments

CHARLOTTESVILLE, Va. , July 16 /PRNewswire-USNewswire/ --The Focused Ultrasound Surgery Foundation has announced that eight leading manufacturers are among the initial sponsors of the 2nd International Symposium on MR-guided Focused Ultrasound, scheduled for October 17 through 20 near...

TOPICS:

High Performance Robotic Ankle Rehabilitation Device

July 16, 2010 12:31 pm | by IITVideos | Videos | Comments

The video shows a 2-dof parallel robot design for ankle rehabilitation. The device can be used for passive and active exercises. In the first case, the patient is passive and the device applies a motion to the patient's foot. In the latter case, the device is passive and the patient...

TOPICS:

Advair Diskus (fluticasone propionate and salmeterol inhalation powder): Stolen Product Warning

July 16, 2010 11:31 am | by U.S. Food & Drug Administration | News | Comments

Certain inhalers stolen from a distribution warehouse in 2009 have been found in some pharmacies. The safety and effectiveness of the stolen inhalers cannot be assured and they should not be used.

TOPICS:

Earnings Preview: UnitedHealth reports 2Q earnings

July 16, 2010 10:45 am | by The Associated Press | News | Comments

Managed care company UnitedHealth Group Inc. reports second-quarter results July 20 before the market opens.WHAT TO WATCH FOR: The Minnetonka, Minn., insurer started 2010 strong. It reported a 21 percent year-over-year profit jump in the first quarter and said it had trimmed the percentage of...

Adjusting Market Research Structures and Activities to Maximize Payer Access & Insights

July 16, 2010 9:35 am | by Bio-Medicine.Org | News | Comments

CHAPEL HILL, N.C. , July 16 /- As the managed markets sector has increased in importance, leading organizations have refocused their market research efforts on delivering actionable insights into the payer world. A market research function that's focused on managed markets should provide...

TOPICS:

Health Management names Levine senior VP

July 16, 2010 7:45 am | by The Associated Press | News | Comments

Hospital operator Health Management Associates Inc. said Friday it named Alan Levine as its new senior vice president of health development operations and government relations.The appointment is effective Aug. 9.Levine most recently served as Secretary of the Louisiana Department of Health and...

Warner Chilcott Announces 3-Month Extension of PDUFA Date on Next Generation Actonel Product

July 16, 2010 7:36 am | by Bio-Medicine.Org | News | Comments

ARDEE, Ireland , July 16 /- Warner Chilcott plc (Nasdaq: WCRX ) announced today that it has received a communication from the U.S. Food & Drug Administration (FDA) related to its next generation Actonel® product (risedronate sodium) delayed-release tablets extending the...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading